TU-2100
N/A
Report date: 2023/01/19 15:50:14
NME
Base Information
Drug NameTU-2100
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBen-Gurion University of the NegevIstituto Biochimico Italiano Giovanni Lorenzini SpaTamarkin Pharmaceutical Innovation Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesIstituto Biochimico Italiano Giovanni Lorenzini SpaTamarkin Pharmaceutical Innovation Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A